Xiaolei Zhuang

Title: Innovations of Xiaolei Zhuang

Introduction

Xiaolei Zhuang is an accomplished inventor based in North Potomac, MD (US). She has made significant contributions to the field of biotherapeutics, particularly in the development of recombinant fusion proteins. With a total of 2 patents, her work focuses on innovative solutions for treating various diseases.

Latest Patents

Xiaolei Zhuang's latest patents include a groundbreaking invention related to human neuregulin-1 (NRG-1) recombinant fusion protein compositions and methods of use thereof. This invention involves a recombinant fusion protein that comprises a fragment of the cardioprotective protein neuregulin-1 (NRG-1) fused to a monoclonal antibody (mAb) backbone. The method aims to treat diseases or conditions in subjects by administering a therapeutically effective amount of the recombinant fusion protein or the pharmaceutical composition that includes it.

Career Highlights

Throughout her career, Xiaolei Zhuang has worked with notable companies in the biotherapeutics sector. She has been associated with Salubris Biotherapeutics, Inc. and Salubris (Chengdu) Biotech Co., Ltd. Her expertise in the field has allowed her to contribute to significant advancements in medical treatments.

Collaborations

Xiaolei Zhuang has collaborated with esteemed colleagues, including John H Li and Shengwei Li. These partnerships have further enhanced her research and development efforts in biotherapeutics.

Conclusion

Xiaolei Zhuang's innovative work in recombinant fusion proteins showcases her dedication to advancing medical science. Her contributions are paving the way for new therapeutic options in treating various health conditions.